Buchumschlag

Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation

BackgroundAfter liver transplantation (LT), there are liver-related, infectious and cardiovascular complications that contribute to reduced graft survival. These conditions are associated with an increase in the Von Willebrand factor antigen (VWF-Ag), which was previously correlated with survival in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wannhoff, Andreas (VerfasserIn) , Rauber, Conrad (VerfasserIn) , Friedrich, Kilian (VerfasserIn) , Rupp, Christian (VerfasserIn) , Stremmel, Wolfgang (VerfasserIn) , Weiss, Karl Heinz (VerfasserIn) , Schemmer, Peter (VerfasserIn) , Gotthardt, Daniel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2017
In: United european gastroenterology journal
Year: 2017, Jahrgang: 5, Heft: 1, Pages: 86-93
ISSN:2050-6414
DOI:10.1177/2050640616650060
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1177/2050640616650060
Verlag, Volltext: https://doi.org/10.1177/2050640616650060
Volltext
Verfasserangaben:Andreas Wannhoff, Conrad Rauber, Kilian Friedrich, Christian Rupp, Wolfgang Stremmel, Karl Heinz Weiss, Peter Schemmer, Daniel N Gotthardt
Beschreibung
Zusammenfassung:BackgroundAfter liver transplantation (LT), there are liver-related, infectious and cardiovascular complications that contribute to reduced graft survival. These conditions are associated with an increase in the Von Willebrand factor antigen (VWF-Ag), which was previously correlated with survival in cirrhotic patients.ObjectiveEvaluate VWF-Ag as a predictive marker of re-transplantation-free survival in patients after LT.MethodsWe measured VWF-Ag in patients after first LT and then followed them prospectively with regard to the primary endpoint, namely re-transplantation-free survival.ResultsThere were 6 out of 80 patients who died or received re-LT during follow-up. In these patients, the median VWF-Ag was 510.6%, which was significantly higher (p?=?0.001) than in the patients who were alive at the end of follow-up (with a median VWF-Ag?=?186.8%). At a cut-off of 286.8%, VWF-Ag was significantly correlated with re-transplantation-free survival (p?
Beschreibung:First published May 10, 2016
Gesehen am 27.11.2018
Beschreibung:Online Resource
ISSN:2050-6414
DOI:10.1177/2050640616650060

Ähnliche Einträge